Polomar Health Services, Inc. (PMHS)

OTCMKTS · Delayed Price · Currency is USD
0.1600
+0.0005 (0.31%)
At close: Feb 18, 2026
Market Cap4.49M
Revenue (ttm)37.04K -32.9%
Net Income-2.43M
EPS-0.09
Shares Out28.05M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,001
Average Volume3,155
Open0.1600
Previous Close0.1595
Day's Range0.1600 - 0.1600
52-Week Range0.0610 - 0.7999
Betan/a
RSI44.07
Earnings DateMay 22, 2026

About Polomar Health Services

Polomar Health Services, Inc. operates as a retail compounding pharmacy. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; and intends to launch PoloMeds for diabetes medications, including metformin compounds, sulfonylureas, and insulin, as well as compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, a... [Read more]

Sector Healthcare
Founded 2023
Employees 3
Stock Exchange OTCMKTS
Ticker Symbol PMHS
Full Company Profile

Financial Performance

Financial Statements